Friday, September 2, 2016
Study Explores Marijuana Use and Fibrosis in Women with HIV and Hepatitis C
›
A study in women coinfected with hepatitis C and HIV found that use of marijuana was not associated with progression to advanced liver fibr...
Gilead to get attorney fees in hepatitis C patent fight with Merck
›
Aug 11 (Reuters) - Gilead Sciences Inc is entitled to receive the attorney fees it incurred related to hepatitis C patent litigation wit...
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Is Gearing Up For Interim HCV Release Next Month
›
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) just reported that it is set to release its latest data from a lead HCV combo trial at the Eu...
Medicare drug spending spike shows need for generics
›
An exclusive Associated Press report, which found that Medicare’s spending on certain drugs soared by 85% in two years, emphasizes the gov...
Community pharmacy helps diagnose people with hepatitis C infection, study shows
›
Pilot project involved community pharmacists in the Isle of Wight testing at-risk adults for hepatitis C virus, hepatitis B, HIV and syphil...
Merck not only loses hep C case against Gilead, it gets stuck with the bill
›
Merck & Co. was sitting pretty earlier this year after winning a legal dispute over sofosbuvir, the active ingredient in Gilead's m...
A Cure For Hepatitis C: Bringing Medication Within Reach For All
›
Here's the promise: There is a cure, a complete cure in a short 12 weeks, for hepatitis C virus (HCV), which the Centers for Disease Co...
›
Home
View web version